Acorda Reports Positive Test Results

January 28, 2008 10:37 AM |

Shares of Acorda Therapeutics Inc. (Nasdaq: ACOR) leaped $5.50 to close at $27.28 following a report that its drug treatment for multiple sclerosis generated test results that did not increase abnormal heart rhythms.

Tags:

Search

About this Entry

This page contains a single entry by published on January 28, 2008 10:37 AM.

IPC Hospitalist Surges In Debut was the previous entry in this blog.

Sales Weaken For McDonald's is the next entry in this blog.

Find recent content on the main index or look in the archives to find all content.

Powered by Movable Type 5.12